Complete Favorable Response after Second-Line Immunotherapy in Stage IV Non-Small Lung Cancer with Visceral Metastases and Operated Brain Metastasis.
Roxana-Andreea Rahnea-NitaLaura-Florentina RebegeaRadu-Valeriu TomaAlexandru NechiforGeorgiana Bianca ConstantinGabriela Rahnea-NitaPublished in: Journal of personalized medicine (2024)
Second-line immunotherapy is beneficial to the survival of patients with NSCLC with disease progression beyond initial chemotherapy. The combination of radiotherapy and immunotherapy has the potential to play an important role in metastatic NSCLC.
Keyphrases
- small cell lung cancer
- locally advanced
- advanced non small cell lung cancer
- squamous cell carcinoma
- early stage
- radiation therapy
- brain metastases
- type diabetes
- radiation induced
- rectal cancer
- free survival
- epidermal growth factor receptor
- metabolic syndrome
- blood brain barrier
- subarachnoid hemorrhage
- tyrosine kinase